Jianxiang Y. Chen

Hangzhou, 311121, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Human ZBP1 is a potent inducer of cell death through mechanisms divergent from mouse ZBP1.

Human ZBP1 is a potent inducer of cell death through mechanisms divergent from mouse ZBP1.

Journal: EMBO reports
Published: November 16, 2025

RNA splicing in cancer cell death regulation: shedding light on the molecular mechanisms and potential clinical applications.

RNA splicing in cancer cell death regulation: shedding light on the molecular mechanisms and potential clinical applications.

Journal: Cell death & disease
Published: September 24, 2025

Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy.

Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy.

Journal: Journal of nanobiotechnology
Published: August 27, 2025

Elemene Augments the Effects of Anti-PD-1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR-130a-5p/SPP/MHC-I Axis.

Elemene Augments the Effects of Anti-PD-1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR-130a-5p/SPP/MHC-I Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 03, 2025

Folate Receptor-Targeted Liposomes Loaded with Actinomycin X2 Enhance Antitumor Potency for HCCLM3 Hepatocellular Carcinoma Both In Vitro and In Vivo.

Folate Receptor-Targeted Liposomes Loaded with Actinomycin X2 Enhance Antitumor Potency for HCCLM3 Hepatocellular Carcinoma Both In Vitro and In Vivo.

Journal: Molecular pharmaceutics
Published: June 09, 2025

Reversal of tumour immune evasion via enhanced MHC-Class-I antigen presentation by a dual-functional RNA regulated system.

Reversal of tumour immune evasion via enhanced MHC-Class-I antigen presentation by a dual-functional RNA regulated system.

Journal: Molecular cancer
Published: May 04, 2025

DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer.

DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer.

Journal: Cell death & disease
Published: April 30, 2025

Key genes of vitamin D metabolism and their roles in the risk and prognosis of cancer.

Key genes of vitamin D metabolism and their roles in the risk and prognosis of cancer.

Journal: Frontiers in genetics
Published: March 23, 2025

The interplay between post-transcriptional RNA regulation and Wnt/β-Catenin signaling in cancer: A Review.

The interplay between post-transcriptional RNA regulation and Wnt/β-Catenin signaling in cancer: A Review.

Journal: International journal of biological macromolecules
Published: March 17, 2025

N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.

N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.

Journal: Cancer science
Published: February 20, 2025

The anti-metastatic effect of elemene in human hepatocellular carcinoma is potentially mediated by inhibiting a novel driver-circBPTF.

The anti-metastatic effect of elemene in human hepatocellular carcinoma is potentially mediated by inhibiting a novel driver-circBPTF.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 17, 2025

The upregulation of GDF15 is controlled epigenetically by oncogenic TCF19 signaling in human hepatocellular carcinoma.

The upregulation of GDF15 is controlled epigenetically by oncogenic TCF19 signaling in human hepatocellular carcinoma.

Journal: iScience
Published: January 24, 2025
Showing 1-12 of 74

Last Updated: 09/26/2026